@article{6e1b4bbc6fe54452a675f9c7bff4844a,
title = "Provider and Practice Characteristics and Perceived Barriers Associated With Different Levels of Adolescent SBIRT Implementation Among a National Sample of US Pediatricians",
abstract = "Pediatrician Screening, Brief Intervention, and Referral to Treatment (SBIRT) practices vary widely, though little is known about the correlates of SBIRT implementation. Using data from a national sample of US pediatricians who treat adolescents (n = 250), we characterized self-reported utilization rates of SBIRT among US pediatricians and identified provider- and practice-level characteristics and barriers associated with SBIRT utilization. All participants completed an electronic survey querying the demographics, practice patterns, and perceived barriers related to SBIRT practices. Our results showed that 88% of respondents reported screening for substance use annually, but only 26% used structured/validated screening instruments. Furthermore, 40% of respondents provided evidence-based brief interventions, and only 11% implemented all core SBIRT practices. Common barriers (eg, confidentiality and insufficient time) and unique provider- and setting-specific barriers to implementation were identified. These findings indicate that although most pediatricians deliver some SBIRT components in their practice, few implement the full SBIRT model, and barriers persist.",
keywords = "Brief Intervention, Screening, adolescents, and Referral to Treatment (SBIRT), implementation, prevention, substance use",
author = "Hammond, {Christopher J.} and Iman Parhami and Young, {Andrea S.} and Matson, {Pamela A.} and Alinsky, {Rachel H.} and Hoover Adger and Sharon Levy and Michelle Horner",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Support for this study came from a National Institute on Drug Abuse (NIDA) and American Academy of Child & Adolescent Psychiatry (AACAP) Resident Training Research Award in Substance Abuse and Addiction (IP), from NIH-Grants, including K12DA000357 (CJH), K23DA044288 (ASY), and K01 DA035387 (PM) and from a NARSAD Young Investigator Award (ASY). Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The authors report no conflicts of interest related to the content in this article. Dr Hammond receives grant support from the National Institute on Drug Abuse (K12DA000357, R34DA050292), the American Academy of Child & Adolescent Psychiatry (AACAP), the Substance Abuse and Mental Health Services Administration (SAMHSA, H79 SP082126-01), the National Network of Depression Centers, and the Armstrong Institute at Johns Hopkins Bayview and serves as a scientific advisor for the National Courts and Science Institute and as a subject matter expert for SAMHSA. Dr Parhami received funding from a National Institute on Drug Abuse (NIDA) and AACAP Resident Training Research Award in Substance Abuse and Addiction. Dr Matson receives grant support from the National Institute on Drug Abuse (K01 DA035387). Dr Young receives or has received research funding from NIDA, the Brain and Behavior Research Foundation, Psychnostics, LLC, and Supernus Pharmaceuticals; has served as a consultant/grant reviewer for PCORI, NIH, and Montana State University; and serves on editorial boards for American Psychological Association journals. Dr Levy{\textquoteright}s preparation of this article was supported in part by the SAMHSA (TI025389), NIAAA (AA021913), and the Conrad N Hilton Foundation (20140273). Drs Alinsky, Adger, and Horner have no disclosures to report. Publisher Copyright: {\textcopyright} The Author(s) 2021.",
year = "2021",
month = sep,
doi = "10.1177/00099228211034334",
language = "English (US)",
volume = "60",
pages = "418--426",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "9-10",
}